Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore
Identifieur interne : 000516 ( Pmc/Corpus ); précédent : 000515; suivant : 000517Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore
Auteurs : Robert HawkinsSource :
- Clinical Biochemist Reviews [ 0159-8090 ] ; 2005.
Abstract
Severe acute respiratory syndrome (SARS) is an emerging disease characterised by fever and atypical pneumonia and caused by a novel coronavirus. Singapore was affected by the global pandemic in early 2003, with 238 cases and 33 deaths. Samples sent to the biochemistry laboratory made up the majority (69%) of all SARS samples, yet remained a minority (29%) of total biochemistry workload. This paper describes the problems encountered and solutions adopted by the biochemistry laboratory at the designated SARS hospital in coping with this epidemic. It provides practical advice for laboratories planning for the handling of samples from future outbreaks.
Url:
PubMed: 16450013
PubMed Central: 1240032
Links to Exploration step
PMC:1240032Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore</title><author><name sortKey="Hawkins, Robert" sort="Hawkins, Robert" uniqKey="Hawkins R" first="Robert" last="Hawkins">Robert Hawkins</name><affiliation><nlm:aff id="af1-cbr26_3pg059">Department of Pathology and Laboratory Medicine, Tan Tock Seng Hospital, Singapore 308433</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">16450013</idno><idno type="pmc">1240032</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240032</idno><idno type="RBID">PMC:1240032</idno><date when="2005">2005</date><idno type="wicri:Area/Pmc/Corpus">000516</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000516</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore</title><author><name sortKey="Hawkins, Robert" sort="Hawkins, Robert" uniqKey="Hawkins R" first="Robert" last="Hawkins">Robert Hawkins</name><affiliation><nlm:aff id="af1-cbr26_3pg059">Department of Pathology and Laboratory Medicine, Tan Tock Seng Hospital, Singapore 308433</nlm:aff></affiliation></author></analytic><series><title level="j">Clinical Biochemist Reviews</title><idno type="ISSN">0159-8090</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Severe acute respiratory syndrome (SARS) is an emerging disease characterised by fever and atypical pneumonia and caused by a novel coronavirus. Singapore was affected by the global pandemic in early 2003, with 238 cases and 33 deaths. Samples sent to the biochemistry laboratory made up the majority (69%) of all SARS samples, yet remained a minority (29%) of total biochemistry workload. This paper describes the problems encountered and solutions adopted by the biochemistry laboratory at the designated SARS hospital in coping with this epidemic. It provides practical advice for laboratories planning for the handling of samples from future outbreaks.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Biochem Rev</journal-id><journal-id journal-id-type="publisher-id">CBR</journal-id><journal-title>Clinical Biochemist Reviews</journal-title><issn pub-type="ppub">0159-8090</issn></journal-meta><article-meta><article-id pub-id-type="pmid">16450013</article-id><article-id pub-id-type="pmc">1240032</article-id><article-id pub-id-type="publisher-id">cbr26_3pg059</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mini Review</subject></subj-group></article-categories><title-group><article-title>Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name><surname>Hawkins</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="af1-cbr26_3pg059"></xref><xref ref-type="corresp" rid="c1-cbr26_3pg059"></xref></contrib></contrib-group><aff id="af1-cbr26_3pg059">Department of Pathology and Laboratory Medicine, Tan Tock Seng Hospital, Singapore 308433</aff><author-notes><corresp id="c1-cbr26_3pg059">For correspondence: Dr Robert Hawkins e-mail:
<email>Robert_Hawkins@ttsh.com.sg</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2005</year></pub-date><volume>26</volume><issue>3</issue><fpage>59</fpage><lpage>64</lpage><copyright-statement>Copyright © 2005 The Australasian Association of Clinical Biochemists Inc.</copyright-statement><copyright-year>2005</copyright-year><abstract><p>Severe acute respiratory syndrome (SARS) is an emerging disease characterised by fever and atypical pneumonia and caused by a novel coronavirus. Singapore was affected by the global pandemic in early 2003, with 238 cases and 33 deaths. Samples sent to the biochemistry laboratory made up the majority (69%) of all SARS samples, yet remained a minority (29%) of total biochemistry workload. This paper describes the problems encountered and solutions adopted by the biochemistry laboratory at the designated SARS hospital in coping with this epidemic. It provides practical advice for laboratories planning for the handling of samples from future outbreaks.</p></abstract></article-meta><notes notes-type="disclaimer"><p>The contents of articles or advertisements in The Clinical Biochemist – Reviews are not to be construed as official statements, evaluations or endorsements by the AACB, its official bodies or its agents. Statements of opinion in AACB publications are those of the contributors. Print Post Approved - PP255003/01665.</p><p>No literary matter in The Clinical Biochemist – Reviews is to be reproduced, stored in a retrieval system or transmitted in any form by electronic or mechanical means, photocopying or recording, without permission. Requests to do so should be addressed to the Editor. ISSN 0159 – 8090.</p></notes></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000516 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000516 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1240032
|texte= Preparing the Biochemistry Laboratory for the Next Outbreak: Lessons from SARS in Singapore
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:16450013" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |